Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Exceptional Value

<< Previous

Bullboard Posts

Next >>

Comment by bmk211on Jan 07, 2025 11:15am

130 Views

Post# 36392403

RE:RE:RE:RE:Exceptional Value

Ruvidar and all of the technology/research discoverd through Theralase are definitely more valuable than the bladder cancer market. There is no question. We are talking about great results with 1 or 2 treatments limited by the clinical study being done with 100% safety. Just think what will be improved and unlocked in the future. CR rates will be much much better.

This is world class.

<< Previous

Bullboard Posts

Next >>

Gold Flora's Gramlin holds court in California cannabis market